SlideShare une entreprise Scribd logo
1  sur  23
Presented By Deshmukh Md Faizan
M. Pharm (2nd Sem)
DEPARTMENT OF PHARMACEUTICAL CHEMISTRY,
R. C. PATEL INSTITUTE OF PHARMACEUTICAL
EDUCATION AND RESEARCH, SHIRPUR
QSAR
Compounds + biological activity
New compounds with
improved biological activity
1
CONTENTS
 Introduction
 Objectives
 Steps in QSAR
 Hansch Analysis
 Free Wilson Approach
 Mixed Approach
 Advantages of QSAR
 Disadvantages of QSAR
 Application of QSAR
2
INTRODUCTION
QSAR is an attempt to remove the element of luck from drug design
by establishing a mathematical relationship in the form of an equation
between biological activity and measurable physicochemical
parameters.
QSAR is mathematical relationship between a biological activity of a
molecular system and its geometric and chemical characteristics.
QSAR(Quantitative Structure Activity Relationship) are based on the
assumption that the structure of molecule (i.e. its geometric, steric and
electronic properties) must contain the features responsible for its
physical, chemical and biological properties.
QSAR in simplest terms, is a method for building computational or
mathematical models which attempts to find a statistically significant
correlation between structure and function.
3
OBJECTIVE
 QSAR makes it easy now to reach the conclusion for any of
the congener that still not in process, in way that whether it
will optimal and profitable or not.
 To predict the biological activities of untested and
sometimes yet unavailable compounds.
 To optimize the existing leads so as to improve their
biological activities.
 Quantitative relationship between the structure and
physiochemical properties of substances and their
biological activity are being used as the foundation stone in
search of new medicines
4
STEPS IN QSAR
5
1. STEPS IN QSAR (STRUCTURE ENTRY AND
MODELLING )
Structure are sketched using standard drawing software's
commercial or freeware
Molecular modelling for the generation of low energy
conformation
Ab intitio-very small molecule, Highly
accurate, High computational costs.
Software- Gaussian.
Semi-empirical-Medium sized
molecules, accurate but computationally
intensive.
Software- MOPAC.
Molecular Mechanics- No restriction
on size, accurate with proper conformational
analysis. Software- CVFF.
6
2.STEPS IN QSAR (DESCRIPTOR GENERATION)
Physico-chemical properties that describe some aspect of
the chemical structure
Empirical Descriptors:-
determined experimentally NMR chemical shift,
Melting point.
Some of the experimentally determined physico-
chemical parameters:
log P = C or g/ C aqu
π x =log P (R-X) – log P (R-H)
Theoretical Descriptors:-
Calculated (theoretical) topological ,BCUT.
7
0D Descriptors:
(i.e. Constitutional Descriptor) molecular weight, no.of
atoms, no of non-H atoms, no. of bonds, no. of heteroatom's,
no. of multiple bonds (nMB), no. of rings, no. of circuits,
no.of H-bond donors, no. of h-bond acceptors, no. of
Nitrogen atoms (nN). Number of certain chemical groups and
functionalities in the molecule. Total no of bonds in the
molecule. Number of rings, no of rings divided by the total
no of atoms.
1D Descriptors:
include structural fragments, hydrophobicity and MR.
1. Hydrophobic Parameters are π and log P.
2. Molar Refractivity (MR)
Determined from the refractive index, the molecular
weight, and density of crystal.
8
2D Descriptors:
Topological Descriptors based on graph theory concepts.
These descriptors have been widely used in QSAR studies.
They help to differentiate the molecules according mostly to
their size.
Isopentane
Graph
representation
Node
Edges
Graph
Invariants(topol
ogical
descriptors)
Isopentane = Four edges, Five nodes and the adjacency
Relationship implicitly in the structure
9
3D Descriptor:
Geometrical Descriptor-
This descriptors using the atomic coordinates (x,y,z) of a
molecules are therefore called 3D descriptors.
Encode the 3D aspect of the structure, Vander Waals
volume, Molecular Surface.
Shadow areas, solvent accessible areas, etc.
Quantum Mechanical Descriptor-
Encode the aspect of the structures that are related to the
electrons.
Electronic descriptor include, HOMO or LUMO
Energies, partial atomic charges, etc.
10
Comparative Molecular Field Analysis (CoMFA)
 The comparative molecular field analysis a grid based
technique, most widely used tools for three dimensional
structure-activity relationship study.
 In this method the molecule-receptor interaction is
represented by the steric and electrostatic field exerted
by each molecule.
11
3.STEPS IN QSAR (FEATURE SELECTION AND
MODELLING)
Traditional techniques in feature selection
Multiple Linear Regression Analysis (MLR):
This is computerised method which is correlate the biological activity
with physico-chemical properties. This method check the impact of each
variable (physico-chemical properties) on biological activity.
Principal Component Analysis (PCA):
This is also computerised method, this method is superior than MLR
since, MLR can correlate 5 times of physico-chemical properties than
compounds, but this method PLA correlate all the physico-chemical
properties with biological activity even these physico-chemical
properties are more than the number of compounds. 12
Partial Least Square (PLS):
Modification of the PCA technique, where the dependent
variables are also extracted into a new component as to
maximize the correlation with the extracted component, Has an
additional advantages of modelling multiple dependent
parameters.
13
4.STEPS IN QSAR (MODEL VALIDATION)
Selection and Validation of QSAR models
The selection and validation of the QSAR model for virtual
screening is of almost importance and should confer to the
following recommendations-
 ƒCareful selection of independent variables
 ƒSignificance of the variables (Statistical parameters)
 Minimum number of compounds per variable
 ƒImportance of the model that corroborates with known
biophysical data.
14
HANSCH ANALYSIS
Hansch proposal that drug action could be divided into two
stages:
1. the transport of the drug to its site of action;
2. the binding of the drug to the target site.
Each of these stages is dependent on the chemical and
physical properties of the drug and its target site.
log 1/C = k1(partition parameter) + k2(electronic parameter)
. + k3(steric parameter)+ k4
where C is the minimum concentration required to cause a
specific biological response.
Hansch equations often takes the general form:
log 1/C = k1P - k2P2 + k3s + k4ES + k5
15
LIMITATION OF HANSCH ANALYSIS
 A large number of compounds is required.
 Lead optimization technique, not a lead discovery
technique.
 Drug Receptor interactions cant be studied.
FREE WILSON APPROACH
 Related biological activity to the presence/absence of a
specific functional group at a specific location on the
parent molecule.
 It is the only numerical method which directly relates
structural features with biological properties, in contrast
to Hansch analysis where the physicochemical properties
are corrrelated with biological activity values.
16
Log BA= contribution of unsubstituted parent compound +
contribution of corresponding substituent
B.A = µ + ∑ aij
Where,
i = number of position at which substitution occurs.
j = number of the substituent at that position.
μ = overall average.
ADVANTAGES OF FREE WILSON APPROACH
 Simple, fast and cheap method where no substitutions
constants like pi, sigma, Es etc. required.
 Greater the complexity of structure, large is the number of
possible substituents at desired positions. Hence efficiency
is high.
 Contribution of each substituent can clearly be identified.
17
DISADVANTAGE
 A large number of analogues need to be synthesised to
represent each different substituent and each different
position of a substituent.
 It is difficult to rationalise why specific substituents are good
or bad for activity.
MIXED APPROACH
“Kubinyi has presents the combination of Hansch and Free
Wilson models as mixed approach”.
log 1C = k1π + k2σ + k3Fs + k Hansch approach
log 1C = π + ∑aij Free-Wilson approach
The mixed approach can be written as;
log 1C =∑aij + ∑ kjΦj + k 18
ADVANTAGES OF QSAR
 Quantifying the relationship between structure and
activity provides an understanding of the effect of
structure on activity.
 It is also possible to make predictions leading to
synthesis of novel analogues.
 The results can be used to help understand interaction
between functional groups in the molecules of greatest
activity with those of their target
19
DISADVANTAGE OF QSAR
 False correlation may arise because biological data that
are subject to considerable experimental error.
 If training dataset is not large enough, the data collected
may not reflect the complete property space.
consequently, many QSAR results cannot be used to
confidently predict the ,most likely compounds of best
activity.
 There are many successful applications but do not expect
QSAR works all time. Also be aware of overfiting
problem.
20
APPLICATION OF QSAR
 Prediction of activity.
 Prediction of toxicity.
 Lead compound optimization.
21
REFERENCE
1. Graham L. Patrick, 2001. An Introduction to Medicinal Chemistry,
Oxford University Press, Page no.258-270.
2. Ashutosh Kar. 2005. Medicinal Chemistry, New Age International
Publishers, Page no.19-33
3. Dr. V. M. Kulkarni, Dr. K.G. Bothara, 2006. Drug Design, Nirali
Prakashan, Page no.8.25-8.27.
22
THANK YOU
23

Contenu connexe

Tendances

De novo drug design
De novo drug designDe novo drug design
De novo drug designmojdeh y
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)Satigayatri
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)suhaspatil114
 
Virtual screening techniques
Virtual screening techniquesVirtual screening techniques
Virtual screening techniquesROHIT PAL
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryAbhik Seal
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Theabhi.in
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxRadhaChafle1
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applicationsAshishkumar3249
 
Docking based screening of drugs.
Docking based screening of drugs.Docking based screening of drugs.
Docking based screening of drugs.Himanshu Yadav
 
Quantitative structure - activity relationship (QSAR)
Quantitative  structure - activity  relationship (QSAR)Quantitative  structure - activity  relationship (QSAR)
Quantitative structure - activity relationship (QSAR)Eswaran Murugesan
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureSaramita De Chakravarti
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningJoon Jyoti Sahariah
 

Tendances (20)

3D QSAR
3D QSAR3D QSAR
3D QSAR
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
3d qsar
3d qsar3d qsar
3d qsar
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
 
Virtual screening techniques
Virtual screening techniquesVirtual screening techniques
Virtual screening techniques
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
Qsar
QsarQsar
Qsar
 
CADD
CADDCADD
CADD
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptx
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applications
 
Docking based screening of drugs.
Docking based screening of drugs.Docking based screening of drugs.
Docking based screening of drugs.
 
Quantitative structure - activity relationship (QSAR)
Quantitative  structure - activity  relationship (QSAR)Quantitative  structure - activity  relationship (QSAR)
Quantitative structure - activity relationship (QSAR)
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screening
 
Qsar
QsarQsar
Qsar
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
SAR & QSAR
SAR & QSARSAR & QSAR
SAR & QSAR
 

Similaire à QSAR by Faizan Deshmukh

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxDrRajeshDas
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxDrRajeshDas
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipRaniBhagat1
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug DesignSagar Magar
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseJayashankar Lakshmanan
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth kRanjeethK2
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship ZarlishAttique1
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA valuesvarun Kundi
 

Similaire à QSAR by Faizan Deshmukh (20)

Qsar
QsarQsar
Qsar
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
Qsar ppt
Qsar pptQsar ppt
Qsar ppt
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
 
E0362430
E0362430E0362430
E0362430
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastase
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth k
 
Drug design
Drug designDrug design
Drug design
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship
 
qsar.pptx
qsar.pptxqsar.pptx
qsar.pptx
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values
 
3D QSAR.pptx
3D QSAR.pptx3D QSAR.pptx
3D QSAR.pptx
 

Dernier

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Pooja Bhuva
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jisc
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxPooja Bhuva
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structuredhanjurrannsibayan2
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxDr. Sarita Anand
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfDr Vijay Vishwakarma
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17Celine George
 

Dernier (20)

How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 

QSAR by Faizan Deshmukh

  • 1. Presented By Deshmukh Md Faizan M. Pharm (2nd Sem) DEPARTMENT OF PHARMACEUTICAL CHEMISTRY, R. C. PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH, SHIRPUR QSAR Compounds + biological activity New compounds with improved biological activity 1
  • 2. CONTENTS  Introduction  Objectives  Steps in QSAR  Hansch Analysis  Free Wilson Approach  Mixed Approach  Advantages of QSAR  Disadvantages of QSAR  Application of QSAR 2
  • 3. INTRODUCTION QSAR is an attempt to remove the element of luck from drug design by establishing a mathematical relationship in the form of an equation between biological activity and measurable physicochemical parameters. QSAR is mathematical relationship between a biological activity of a molecular system and its geometric and chemical characteristics. QSAR(Quantitative Structure Activity Relationship) are based on the assumption that the structure of molecule (i.e. its geometric, steric and electronic properties) must contain the features responsible for its physical, chemical and biological properties. QSAR in simplest terms, is a method for building computational or mathematical models which attempts to find a statistically significant correlation between structure and function. 3
  • 4. OBJECTIVE  QSAR makes it easy now to reach the conclusion for any of the congener that still not in process, in way that whether it will optimal and profitable or not.  To predict the biological activities of untested and sometimes yet unavailable compounds.  To optimize the existing leads so as to improve their biological activities.  Quantitative relationship between the structure and physiochemical properties of substances and their biological activity are being used as the foundation stone in search of new medicines 4
  • 6. 1. STEPS IN QSAR (STRUCTURE ENTRY AND MODELLING ) Structure are sketched using standard drawing software's commercial or freeware Molecular modelling for the generation of low energy conformation Ab intitio-very small molecule, Highly accurate, High computational costs. Software- Gaussian. Semi-empirical-Medium sized molecules, accurate but computationally intensive. Software- MOPAC. Molecular Mechanics- No restriction on size, accurate with proper conformational analysis. Software- CVFF. 6
  • 7. 2.STEPS IN QSAR (DESCRIPTOR GENERATION) Physico-chemical properties that describe some aspect of the chemical structure Empirical Descriptors:- determined experimentally NMR chemical shift, Melting point. Some of the experimentally determined physico- chemical parameters: log P = C or g/ C aqu π x =log P (R-X) – log P (R-H) Theoretical Descriptors:- Calculated (theoretical) topological ,BCUT. 7
  • 8. 0D Descriptors: (i.e. Constitutional Descriptor) molecular weight, no.of atoms, no of non-H atoms, no. of bonds, no. of heteroatom's, no. of multiple bonds (nMB), no. of rings, no. of circuits, no.of H-bond donors, no. of h-bond acceptors, no. of Nitrogen atoms (nN). Number of certain chemical groups and functionalities in the molecule. Total no of bonds in the molecule. Number of rings, no of rings divided by the total no of atoms. 1D Descriptors: include structural fragments, hydrophobicity and MR. 1. Hydrophobic Parameters are π and log P. 2. Molar Refractivity (MR) Determined from the refractive index, the molecular weight, and density of crystal. 8
  • 9. 2D Descriptors: Topological Descriptors based on graph theory concepts. These descriptors have been widely used in QSAR studies. They help to differentiate the molecules according mostly to their size. Isopentane Graph representation Node Edges Graph Invariants(topol ogical descriptors) Isopentane = Four edges, Five nodes and the adjacency Relationship implicitly in the structure 9
  • 10. 3D Descriptor: Geometrical Descriptor- This descriptors using the atomic coordinates (x,y,z) of a molecules are therefore called 3D descriptors. Encode the 3D aspect of the structure, Vander Waals volume, Molecular Surface. Shadow areas, solvent accessible areas, etc. Quantum Mechanical Descriptor- Encode the aspect of the structures that are related to the electrons. Electronic descriptor include, HOMO or LUMO Energies, partial atomic charges, etc. 10
  • 11. Comparative Molecular Field Analysis (CoMFA)  The comparative molecular field analysis a grid based technique, most widely used tools for three dimensional structure-activity relationship study.  In this method the molecule-receptor interaction is represented by the steric and electrostatic field exerted by each molecule. 11
  • 12. 3.STEPS IN QSAR (FEATURE SELECTION AND MODELLING) Traditional techniques in feature selection Multiple Linear Regression Analysis (MLR): This is computerised method which is correlate the biological activity with physico-chemical properties. This method check the impact of each variable (physico-chemical properties) on biological activity. Principal Component Analysis (PCA): This is also computerised method, this method is superior than MLR since, MLR can correlate 5 times of physico-chemical properties than compounds, but this method PLA correlate all the physico-chemical properties with biological activity even these physico-chemical properties are more than the number of compounds. 12
  • 13. Partial Least Square (PLS): Modification of the PCA technique, where the dependent variables are also extracted into a new component as to maximize the correlation with the extracted component, Has an additional advantages of modelling multiple dependent parameters. 13
  • 14. 4.STEPS IN QSAR (MODEL VALIDATION) Selection and Validation of QSAR models The selection and validation of the QSAR model for virtual screening is of almost importance and should confer to the following recommendations-  ƒCareful selection of independent variables  ƒSignificance of the variables (Statistical parameters)  Minimum number of compounds per variable  ƒImportance of the model that corroborates with known biophysical data. 14
  • 15. HANSCH ANALYSIS Hansch proposal that drug action could be divided into two stages: 1. the transport of the drug to its site of action; 2. the binding of the drug to the target site. Each of these stages is dependent on the chemical and physical properties of the drug and its target site. log 1/C = k1(partition parameter) + k2(electronic parameter) . + k3(steric parameter)+ k4 where C is the minimum concentration required to cause a specific biological response. Hansch equations often takes the general form: log 1/C = k1P - k2P2 + k3s + k4ES + k5 15
  • 16. LIMITATION OF HANSCH ANALYSIS  A large number of compounds is required.  Lead optimization technique, not a lead discovery technique.  Drug Receptor interactions cant be studied. FREE WILSON APPROACH  Related biological activity to the presence/absence of a specific functional group at a specific location on the parent molecule.  It is the only numerical method which directly relates structural features with biological properties, in contrast to Hansch analysis where the physicochemical properties are corrrelated with biological activity values. 16
  • 17. Log BA= contribution of unsubstituted parent compound + contribution of corresponding substituent B.A = µ + ∑ aij Where, i = number of position at which substitution occurs. j = number of the substituent at that position. μ = overall average. ADVANTAGES OF FREE WILSON APPROACH  Simple, fast and cheap method where no substitutions constants like pi, sigma, Es etc. required.  Greater the complexity of structure, large is the number of possible substituents at desired positions. Hence efficiency is high.  Contribution of each substituent can clearly be identified. 17
  • 18. DISADVANTAGE  A large number of analogues need to be synthesised to represent each different substituent and each different position of a substituent.  It is difficult to rationalise why specific substituents are good or bad for activity. MIXED APPROACH “Kubinyi has presents the combination of Hansch and Free Wilson models as mixed approach”. log 1C = k1π + k2σ + k3Fs + k Hansch approach log 1C = π + ∑aij Free-Wilson approach The mixed approach can be written as; log 1C =∑aij + ∑ kjΦj + k 18
  • 19. ADVANTAGES OF QSAR  Quantifying the relationship between structure and activity provides an understanding of the effect of structure on activity.  It is also possible to make predictions leading to synthesis of novel analogues.  The results can be used to help understand interaction between functional groups in the molecules of greatest activity with those of their target 19
  • 20. DISADVANTAGE OF QSAR  False correlation may arise because biological data that are subject to considerable experimental error.  If training dataset is not large enough, the data collected may not reflect the complete property space. consequently, many QSAR results cannot be used to confidently predict the ,most likely compounds of best activity.  There are many successful applications but do not expect QSAR works all time. Also be aware of overfiting problem. 20
  • 21. APPLICATION OF QSAR  Prediction of activity.  Prediction of toxicity.  Lead compound optimization. 21
  • 22. REFERENCE 1. Graham L. Patrick, 2001. An Introduction to Medicinal Chemistry, Oxford University Press, Page no.258-270. 2. Ashutosh Kar. 2005. Medicinal Chemistry, New Age International Publishers, Page no.19-33 3. Dr. V. M. Kulkarni, Dr. K.G. Bothara, 2006. Drug Design, Nirali Prakashan, Page no.8.25-8.27. 22